Ying XY[Author] - Search Results

Year	Number of Results
1986	1
2002	1
2005	1
2007	1
2008	4
2009	1
2010	1
2011	1
2012	1
2013	3
2014	1
2015	1
2016	3
2017	7
2018	5
2019	10
2020	6
2021	1
2022	2
2023	2
2024	1

1

Mechanism investigation of ethosomes transdermal permeation.

Niu XQ, Zhang DP, Bian Q, Feng XF, Li H, Rao YF, Shen YM, Geng FN, Yuan AR, Ying XY, Gao JQ. Niu XQ, et al. Among authors: ying xy. Int J Pharm X. 2019 Aug 7;1:100027. doi: 10.1016/j.ijpx.2019.100027. eCollection 2019 Dec. Int J Pharm X. 2019. PMID: 31517292 Free PMC article.

2

Stimuli-responsive Drug Delivery Systems as an Emerging Platform for Treatment of Rheumatoid Arthritis.

Xu XL, Lu KJ, Yao XQ, Ying XY, Du YZ. Xu XL, et al. Among authors: ying xy. Curr Pharm Des. 2019;25(2):155-165. doi: 10.2174/1381612825666190321104424. Curr Pharm Des. 2019. PMID: 30907308 Review.

3

Giant cyst in heterotopic pregnancy: A case report.

Kong YY, Chanda K, Ying XY. Kong YY, et al. Among authors: ying xy. World J Clin Cases. 2023 Jun 6;11(16):3864-3869. doi: 10.12998/wjcc.v11.i16.3864. World J Clin Cases. 2023. PMID: 37383131 Free PMC article.

4

Yikang decoction facilitates embryo implantation in mice with implantation dysfunction via upregulation of LIF expression.

Xiao X, Liang SL, Liu YH, Wang J, Huang Q, Chen HL, Du Y, Ying XY. Xiao X, et al. Among authors: ying xy. Transpl Immunol. 2022 Dec;75:101662. doi: 10.1016/j.trim.2022.101662. Epub 2022 Jul 8. Transpl Immunol. 2022. PMID: 35810979

5

Paclitaxel/hydroxypropyl-β-cyclodextrin complex-loaded liposomes for overcoming multidrug resistance in cancer chemotherapy.

Shen Q, Shen Y, Jin F, Du YZ, Ying XY. Shen Q, et al. Among authors: ying xy. J Liposome Res. 2020 Mar;30(1):12-20. doi: 10.1080/08982104.2019.1579838. Epub 2019 Mar 14. J Liposome Res. 2020. PMID: 30741058

6

Polysialic-Acid-Based Micelles Promote Neural Regeneration in Spinal Cord Injury Therapy.

Wang XJ, Peng CH, Zhang S, Xu XL, Shu GF, Qi J, Zhu YF, Xu DM, Kang XQ, Lu KJ, Jin FY, Yu RS, Ying XY, You J, Du YZ, Ji JS. Wang XJ, et al. Among authors: ying xy. Nano Lett. 2019 Feb 13;19(2):829-838. doi: 10.1021/acs.nanolett.8b04020. Epub 2019 Jan 8. Nano Lett. 2019. PMID: 30605619

7

MiRNA-584 suppresses the progression of NK/T-cell lymphoma by targeting FOXO1.

Wang CC, Han L, Hou YH, Ying XY. Wang CC, et al. Among authors: ying xy. Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4404-4411. doi: 10.26355/eurrev_202004_21022. Eur Rev Med Pharmacol Sci. 2020. PMID: 32373978 Free article.

8

Highly Integrated Nanoplatform Based on an E-Selectin-Targeting Strategy for Metastatic Breast Cancer Treatment.

Xu XL, Zhu ML, Liu D, Shu GF, Qi J, Lu Y, Wang F, Ying XY, Chen J, Du YZ. Xu XL, et al. Among authors: ying xy. Mol Pharm. 2019 Aug 5;16(8):3694-3702. doi: 10.1021/acs.molpharmaceut.9b00616. Epub 2019 Jul 16. Mol Pharm. 2019. PMID: 31268329

9

A Fuzzy Expert System to Predict the Risk of Postpartum Hemorrhage.

Doomah YH, Xu SY, Cao LX, Liang SL, Nuer-Allornuvor GF, Ying XY. Doomah YH, et al. Among authors: ying xy. Acta Inform Med. 2019 Dec;27(5):318-3326. doi: 10.5455/aim.2019.27.318-326. Acta Inform Med. 2019. PMID: 32210499 Free PMC article.

10

Preparation of Ethyl Cellulose Microspheres for Sustained Release of Sodium Bicarbonate.

Wu JH, Wang XJ, Li SJ, Ying XY, Hu JB, Xu XL, Kang XQ, You J, Du YZ. Wu JH, et al. Among authors: ying xy. Iran J Pharm Res. 2019 Spring;18(2):556-568. doi: 10.22037/ijpr.2019.1100651. Iran J Pharm Res. 2019. PMID: 31531041 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

50 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year